鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02251 鹰瞳科技-B

已收盘 09-09 16:00:00

8.800

+0.700

+8.64%

最高8.900	最低8.415	成交量3.43万
今开8.415	昨收8.100	日振幅5.99%
总市值8.89亿	流通市值8.89亿	总股本1.01亿
成交额29.62万	换手率0.03%	流通股本1.01亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02251","market":"HK","secType":"STK","nameCN":"鹰瞳科技-B","latestPrice":8.8,"timestamp":1788940800007,"preClose":8.1,"halted":0,"volume":34300,"delay":0,"changeRate":0.08641975308641989,"floatShares":101000000,"shares":101000000,"eps":-0.28573025710700706,"marketStatus":"已收盘","change":0.7,"latestTime":"09-09 16:00:00","open":8.415,"high":8.9,"low":8.415,"amount":296244,"amplitude":0.059877,"askPrice":8.97,"askSize":5200,"bidPrice":8.01,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-0.8277332719680038,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789003800000},"marketStatusCode":5,"adr":0,"listingDate":1636041600000,"exchange":"SEHK","adjPreClose":8.1,"openAndCloseTimeList":[[1788917400000,1788926400000],[1788930000000,1788940800000]],"volumeRatio":1.376404,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02251","defaultTab":"news","newsList":[{"id":"1107399264","title":"鹰瞳科技-B回购3.43万股股份，总额约29.62万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107399264","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107399264?lang=zh_cn&edition=full","pubTime":"2026-09-09 19:22","pubTimestamp":1788952949,"startTime":"0","endTime":"0","summary":"北京鹰瞳科技发展股份有限公司于2026年9月9日发布翌日披露报表，宣布在香港联交所场内回购3.43万股H股股份，占该公司回购前已发行股份总数约0.034%。此次回购每股价格介乎港币8.42元至8.90元，总耗资约29.62万港元。公司回购授权于2026年6月26日通过，总额度为10,137,961股，截至目前累计回购392,600股，占授权通过当日已发行股份数目的0.3873%，后续尚有约974.54万股的可回购空间。本次公告由公司董事张大磊签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"鹰瞳科技-B回购3.43万股股份，总额约29.62万港元","news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666877765","title":"鹰瞳科技-B(02251)9月9日斥资29.6万港元回购3.43万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666877765","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666877765?lang=zh_cn&edition=full","pubTime":"2026-09-09 19:19","pubTimestamp":1788952787,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布公告，于2026年9月9日斥资29.6万港元回购3.43万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494035.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665328499","title":"万东医疗：已构建起覆盖全线、技术领先的高端医学影像产品矩阵","url":"https://stock-news.laohu8.com/highlight/detail?id=2665328499","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665328499?lang=zh_cn&edition=full","pubTime":"2026-09-08 15:34","pubTimestamp":1788852848,"startTime":"0","endTime":"0","summary":"谢谢万东医疗回复：您好，公司已构建起覆盖全线、技术领先的高端医学影像产品矩阵，并在多个关键领域实现了国产“首创”或“领先”，打破了国外技术垄断。公司进一步拓展动物医疗业务，构建“人-动物”健康领域的多元化影像解决方案，以先进的影像设备提升动物医疗服务水平和福利，开辟第二增长曲线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800019612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1189","BK0070","02251","000973.SH","BK0146","600055","BK0251","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127863015","title":"鹰瞳科技-B 9月4日回购1.03万股，涉资约8.60万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127863015","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127863015?lang=zh_cn&edition=full","pubTime":"2026-09-04 20:46","pubTimestamp":1788526011,"startTime":"0","endTime":"0","summary":"北京鹰瞳科技发展股份有限公司于2026年9月4日公告，该公司当日于香港联交所场内回购H股合计10,300股，占本次事项前现有已发行股本约0.01%。每股回购价格介乎每股7.99港元至9港元，合计涉资约86,043.50港元。本次回购完成后，公司已发行股份从101,031,613股降至101,021,313股，库存股份由2,536,400股增至2,546,700股。公司目前的已发行股份总数为103,568,013股。公司确认，本次回购事项已获得董事会批准，相关程序符合《香港联交所证券上市规则》和其他适用法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"鹰瞳科技-B 9月4日回购1.03万股，涉资约8.60万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664833497","title":"鹰瞳科技-B(02251.HK)9月4日耗资约8.6万港元回购1.03万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664833497","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664833497?lang=zh_cn&edition=full","pubTime":"2026-09-04 20:44","pubTimestamp":1788525884,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1189","02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164530591","title":"鹰瞳科技-B更新2026年8月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1164530591","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164530591?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:50","pubTimestamp":1788511819,"startTime":"0","endTime":"0","summary":"北京鹰瞳科技发展股份有限公司于2026年9月4日发布2026年8月止月份的证券变动月报表。公告显示，截至2026年8月31日，公司注册股本为人民币103,568,013元，每股面值人民币1元，较上月无变化。报告期内，公司未发生新增发行、购回、注销或库藏股的变动，也未涉及任何股份期权、股权激励计划或认股权证、可换股票据等其他性质的增减。本次公告由公司董事张大磊签署。至2026年8月末，公司股本结构保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663078811","title":"港股异动 | 鹰瞳科技-B(02251.HK)跌近14% 多重因素拖累业绩 上半年亏损扩大至4885.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663078811","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663078811?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:25","pubTimestamp":1788161138,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183238498","title":"鹰瞳科技-B2026年上半年营收6,729.1万元，经调整净亏损4,885.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183238498","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183238498?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:57","pubTimestamp":1787929044,"startTime":"0","endTime":"0","summary":"根据公告，2026年上半年，鹰瞳科技-B实现营收6,729.1万元，同比下降19.6%，主要系落实更严格的代理商选择策略及收紧信用期政策所致。期内经调整净亏损4,885.60万元，而上年同期盈利44.3万元。视网膜检测AI：实现营收3,689.8万元，同比下降35.6%，主要因代理商精简结构及信用政策调整导致高毛利软件收入下滑。抗压能力监测AI：营收36万元，为新投入商业化的业务，处于起步阶段。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"鹰瞳科技-B2026年上半年营收6,729.1万元，经调整净亏损4,885.60万元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130100081","title":"鹰瞳科技-B（02251）发布盈利警告 预计2026年中期由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=1130100081","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130100081?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:05","pubTimestamp":1787313949,"startTime":"0","endTime":"0","summary":"2026年8月21日，北京鹰瞳科技发展股份有限公司公告称，经对截至2026年6月30日止六个月的未审核综合管理账目进行初步评估，预计期间将录得净亏损不超过人民币50.0百万元；而2025年同期录得净溢利约人民币0.44百万元，公司业绩由盈转亏。公司预计将于2026年8月底之前公布截至2026年6月30日止六个月的未审核综合业绩，并提醒股东及潜在投资者审慎行事，不应单凭本公告内容买卖公司证券。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163380628","title":"鹰瞳科技-B（02251）将于8月28日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1163380628","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163380628?lang=zh_cn&edition=full","pubTime":"2026-08-18 18:55","pubTimestamp":1787050558,"startTime":"0","endTime":"0","summary":"鹰瞳科技-B（02251）8月18日公告称，公司董事会定于2026年8月28日（星期五）召开会议，主要议程包括：\n\n1. 审议及批准公司及其附属公司截至2026年6月30日止六个月的中期业绩及其发布；  \n\n2. 研究及考虑建议派付中期股息（如有）。\n\n公告同时列示了当前董事会成员组成，包括执行董事张大磊、王林、秦勇、魏宇博，以及独立非执行董事武阳丰、黄彦林、吴浩然。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659430136","title":"港股异动 | 云知声(09678)涨超5% 正式发布自研医学影像多模态大模型“U2-RadiMed”","url":"https://stock-news.laohu8.com/highlight/detail?id=2659430136","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659430136?lang=zh_cn&edition=full","pubTime":"2026-08-13 14:26","pubTimestamp":1786602394,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，云知声涨超5%，截至发稿，涨3.89%，报76.15港元，成交额7088.55万港元。消息面上，8月13日，云知声发布公告，继U2-Med三医大模型发布后，公司近日正式发布自研医学影像多模态大模型“U2-RadiMed”。U2-RadiMed的发布，标志着公司大模型能力正式进入医学影像这一更复杂、更专业的临床核心场景，进一步完善了公司“通用基座大模型—三医专业大模型—医学影像多模态大模型”的医疗AI产品体系，巩固了公司在医疗人工智能领域的技术领先地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479390.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","KCAI","BK4585","WISE","02251","09678","GPTZ","EPAI","BK1109","LRNZ","BK4588","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659891251","title":"云知声(09678.HK)发布自研医学影像多模态大模型“U2-RadiMed”","url":"https://stock-news.laohu8.com/highlight/detail?id=2659891251","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659891251?lang=zh_cn&edition=full","pubTime":"2026-08-13 08:04","pubTimestamp":1786579453,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1109","09678","02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658213987","title":"沙利文白皮书：AGI重构医学影像，全链路赋能整体影像能力从66%提升至97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658213987","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658213987?lang=zh_cn&edition=full","pubTime":"2026-08-10 18:02","pubTimestamp":1786356156,"startTime":"0","endTime":"0","summary":"当人工智能从识别单个病灶走向理解完整检查项目，当医学影像数据从静态存储转化为可训练、可验证、可迭代的智能资产，当医生由AI工具的使用者逐步成为智能能力的共同创造者——医学影像产业正迈入以真实场景、高质量数据、通用模型和生态协同共同驱动的新阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608103836728385.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608103836728385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0498741890.SGD","LU0368265764.SGD","BK4017","GDXJ","02251","BK1189","BK4207","LU0055631609.USD","AGBK","LU0496367417.USD","LU0498741114.HKD","AGI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143329499","title":"鹰瞳科技-B发布2026年7月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1143329499","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143329499?lang=zh_cn&edition=full","pubTime":"2026-08-04 13:20","pubTimestamp":1785820841,"startTime":"0","endTime":"0","summary":"北京鹰瞳科技发展股份有限公司于2026年8月4日披露2026年7月股份变动月报表。报告期截至2026年7月31日，公司注册股本及总股本均保持不变，为103,568,013股，每股面值为人民币1元。报告显示，期初公司已发行股份为101,262,213股，库存股份为2,305,800股，总股本为103,568,013股。由于当月实施股份回购230,600股后，该部分股份被转为库存股份，导致报告期末已发行股份减少至101,031,613股，库存股份增至2,536,400股，但总股本仍为103,568,013股。这些回购股份目前全部以库存股份形式持有。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654440034","title":"联影医疗获得发明专利授权：“医学影像设备的控制方法、医学影像设备及介质”","url":"https://stock-news.laohu8.com/highlight/detail?id=2654440034","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654440034?lang=zh_cn&edition=full","pubTime":"2026-07-25 03:40","pubTimestamp":1784922053,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示联影医疗新获得一项发明专利授权，专利名为“医学影像设备的控制方法、医学影像设备及介质”，专利申请号为CN202311525271.4，授权日为2026年7月24日。本申请可以提高用户对医学影像设备的操作效率。今年以来联影医疗新获得专利授权207个，较去年同期增加了33.55%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072500003098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688271","BK0251","02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181410547","title":"鹰瞳科技-B：7月20日回购12,700股，总额约13.20万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1181410547","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181410547?lang=zh_cn&edition=full","pubTime":"2026-07-20 19:51","pubTimestamp":1784548298,"startTime":"0","endTime":"0","summary":"鹰瞳科技-B于2026年7月20日公告，公司当日于香港联交所回购12,700股股份，约占回购前已发行股份总数的0.013%。此次回购价格区间为每股9.96港元至11.48港元，合计耗资约13.20万港元。本次回购后，公司已发行股份总数变动至101,031,613股，库藏股数增至2,536,400股，合计股本总数仍为103,568,013股。公司于2026年6月26日通过购回授权，授权购回股份总数为10,137,961股。公司表示，此次回购遵守相关上市规则及适用法律。公告由公司董事张大磊签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"鹰瞳科技-B：7月20日回购12,700股，总额约13.20万港元","news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652218961","title":"鹰瞳科技-B(02251)7月20日斥资13.2万港元回购1.27万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652218961","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652218961?lang=zh_cn&edition=full","pubTime":"2026-07-20 19:47","pubTimestamp":1784548042,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布公告，于2026年7月20日斥资13.2万港元回购1.27万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143179126","title":"鹰瞳科技-B回购0.40万股，耗资约4.15万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143179126","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143179126?lang=zh_cn&edition=full","pubTime":"2026-07-16 18:36","pubTimestamp":1784198172,"startTime":"0","endTime":"0","summary":"北京鹰瞳科技发展股份有限公司于2026年7月16日发布公告，披露最近一次股份回购交易情况。公告显示，公司于2026年7月16日在香港联交所场内回购4,000股H股股份，占本次回购前公司已发行股本约0.004%。本次回购的最高价格为每股10.52港元，最低价格为每股10.29港元，累计耗资约41,510港元。本次回购完成后，公司已发行股份数减少至101,044,313股，库藏股数量增至2,523,700股。公司表示，回购过程已遵守香港联交所上市规则及相关法律的相关规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"鹰瞳科技-B回购0.40万股，耗资约4.15万港元","news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651601445","title":"鹰瞳科技(02251.HK)7月16日斥资约4.15万港元回购4000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651601445","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651601445?lang=zh_cn&edition=full","pubTime":"2026-07-16 18:35","pubTimestamp":1784198133,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651452459","title":"鹰瞳科技-B(02251)7月15日斥资21.68万港元回购2.22万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651452459","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651452459?lang=zh_cn&edition=full","pubTime":"2026-07-15 18:57","pubTimestamp":1784113038,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鹰瞳科技-B(02251)发布公告，于2026年7月15日斥资21.68万港元回购2.22万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1467987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02251","BK1189"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.1465},{"period":"3month","weight":-0.3141},{"period":"6month","weight":-0.3047},{"period":"1year","weight":-0.4512},{"period":"ytd","weight":-0.2913}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":-0.0137},{"period":"3month","weight":0.0373},{"period":"6month","weight":-0.0155},{"period":"1year","weight":-0.0124},{"period":"ytd","weight":-0.0122}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京鹰瞳科技发展股份有限公司是一家中国公司，主要专注于提供人工智能视网膜影像识别的早期检测诊断及健康风险评估解决方案。该公司的产品管线包括为医疗机构和大健康领域提供的眼底诊断人工智能SaMD、健康风险评估系统以及相应的智能硬件设备，打造了集软件和硬件于一体的解决方案。该公司还推出了针对儿童和青少年近视及斜弱视问题的人工智能治疗产品，实现了从检测、评估到治疗的一站式解决方案。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.071183},{"month":2,"riseRate":0.8,"avgChangeRate":0.116001},{"month":3,"riseRate":0.2,"avgChangeRate":-0.086289},{"month":4,"riseRate":0.2,"avgChangeRate":-0.01326},{"month":5,"riseRate":0.4,"avgChangeRate":-0.093467},{"month":6,"riseRate":0.6,"avgChangeRate":0.028876},{"month":7,"riseRate":0.2,"avgChangeRate":-0.050981},{"month":8,"riseRate":0.4,"avgChangeRate":-0.040463},{"month":9,"riseRate":0.2,"avgChangeRate":-0.059338},{"month":10,"riseRate":0.25,"avgChangeRate":-0.013194},{"month":11,"riseRate":0.75,"avgChangeRate":0.109538},{"month":12,"riseRate":0.4,"avgChangeRate":-0.09117}],"exchange":"SEHK","name":"鹰瞳科技-B","nameEN":"AIRDOC-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鹰瞳科技-B,02251,鹰瞳科技-B股票,鹰瞳科技-B股票老虎,鹰瞳科技-B股票老虎国际,鹰瞳科技-B行情,鹰瞳科技-B股票行情,鹰瞳科技-B股价,鹰瞳科技-B股市,鹰瞳科技-B股票价格,鹰瞳科技-B股票交易,鹰瞳科技-B股票购买,鹰瞳科技-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}